Pharma launch mastery: Turning unmet needs into market success
December 15, 2025
Early performance defines pharma launch success. Tune in to learn why fundamentals, patient access, and people matter most—while balancing innovation with proven strategies.
Over $200 billion in pharmaceutical revenue is at risk from loss of exclusivity by 2030, and more than 80% of launches set their long-term trajectory within the first six months—making early performance critical.
In this episode of Shaping Healthcare, Yuliana, Senior Director at Citius Healthcare Consulting, shares proven strategies for achieving launch excellence in a fast-paced, competitive market. Drawing on experience across global launches, she emphasizes fundamentals that remain constant despite evolving trends like AI and post-COVID dynamics.
Key takeaways:
- Early performance in the first six months defines the long-term success of a pharma launch.
- Mastering the fundamentals—the four Ps—remains essential even amid evolving trends like AI.
- Investing in people and patient access creates a sustainable competitive advantage.
- Balancing innovation with proven strategies ensures consistent results.